TITLE

Analysis of differential gene expression in plurihormonal pituitary adenomas using bead-based fiber-optic arrays

AUTHOR(S)
Jiang, Zhiquan; Gui, Songbai; Zhang, Yazhuo
PUB. DATE
July 2012
SOURCE
Journal of Neuro-Oncology;Jul2012, Vol. 108 Issue 3, p341
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Plurihormonal pituitary adenomas (PHPAs) are defined as those pituitary adenomas secreting two or more hormones that differ in chemical composition, immunoreactivity, and biologic effects. Since the pathogenesis of these adenomas is not well understood, our study aimed to explore mechanisms underlying the pathogenesis of PHPAs. We used bead-based fiber-optic arrays (Illumina Human GeneChip WG-6 v3.0) to examine the gene expression profiles in seven PHPAs compared with three normal pituitary glands. Four differentially expressed genes were chosen randomly for validation by quantitative real-time reverse-transcription polymerase chain reaction. We then performed pathway analysis of all differentially expressed genes using the Kyoto Encyclopedia of Genes and Genomes. Our array analysis showed significant increases in the expression of 6 genes and decreases in 334 genes and 15 expressed sequence tags in the PHPAs. Bioinformatic analysis showed that genes HIGD1B, EPS8, ECT2, and BTG2 might play an important role in the tumorigenesis and progression of PHPAs. Pathway analysis showed that the p53 and Notch signaling pathways may play an important role in tumorigenesis and progression of PHPAs, and extracellular matrix (ECM)-receptor interactions likely play a role in the inhibition of invasion and metastasis in these tumors. Our data suggested that there are numerous aberrantly expressed genes and pathways involved in the pathogenesis of PHPAs. Bead-based fiber-optic arrays combined with pathway analysis of gene expression data appears to be a valid method for investigating the pathogenesis of tumors.
ACCESSION #
76350873

 

Related Articles

  • Analysis of differential gene expression by fiber-optic BeadArray and pathway in prolactinomas. Jiang, Zhiquan; Gui, Songbo; Zhang, Yazhuo // Endocrine (1355008X);Dec2010, Vol. 38 Issue 3, p360 

    Prolactinomas are the most common secretory pituitary tumors; however, their pathogenesis is unclear. In order to explore the pathogenesis of prolactinomas, we used fiber-optic BeadArray to examine gene expression profiles in five prolactinomas compared with three normal pituitaries. Three...

  • Commentary on 'Expression of dopamine 2 receptor subtypes mRNA in clinically nonfunctioning pituitary adenomas'. Salmaggi, Andrea; Lodrini, Sandro // Neurological Sciences;Apr2012, Vol. 33 Issue 2, p281 

    No abstract available.

  • Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas. Su, Zhipeng; Wang, Chengde; Wu, Jinsen; Jiang, Xiaolong; Chen, Yunxiang; Chen, Yong; Zheng, Weiming; Zhuge, Qichuan; Wu, Zhebao; Zeng, Yanjun // Neurological Sciences;Apr2012, Vol. 33 Issue 2, p275 

    Dopamine receptor agonists (DAs) can reduce hormone release and tumor mass in the majority of prolactinomas, whereas such effects are controversial in clinically nonfunctioning pituitary adenomas (NFPAs). Whether expression of dopamine 2 receptor (D2R) is different in subgroups of NFPAs has not...

  • MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer. Shuli Liang; Lijie He; Xiaodi Zhao; Yu Miao; Yong Gu; Changcun Guo; Zengfu Xue; Weijia Dou; Fengrong Hu; Kaichun Wu; Yongzhan Nie; Daiming Fan // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Background: MicroRNAs (miRNAs) are important regulators that play key roles in tumorigenesis and tumor progression. A previous report has shown that let-7 family members can act as tumor suppressors in many cancers. Through miRNA array, we found that let-7f was downregulated in the highly...

  • Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Wang, J; Tian, X; Han, R; Zhang, X; Wang, X; Shen, H; Xue, L; Liu, Y; Yan, X; Shen, J; Mannoor, K; Deepak, J; Donahue, J M; Stass, S A; Xing, L; Jiang, F // Oncogene;2/27/2014, Vol. 33 Issue 9, p1181 

    We have previously shown that miR-486-5p is one of the most downregulated micro RNAs in lung cancer. The objective of the study was to investigate the role of miR-486-5p in the progression and metastasis of non-small-cell lung cancer (NSCLC). We evaluated miR-486-5p expression status on 76...

  • Detection and Clinical Significance of CD44v6 and Integrin-β1 in Pancreatic Cancer Patients using a Triplex Real-Time RT-PCR Assay. Zhou, Gang; Chiu, David; Qin, Dajiang; Niu, Lizhi; Cai, Jinlei; He, Lihua; Huang, Wenhao; Xu, Kecheng // Applied Biochemistry & Biotechnology;Aug2012, Vol. 167 Issue 8, p2257 

    The cell adhesion molecules CD44v6 and integrin-β1 are associated with the progression and metastasis of cancer. A novel triplex real-time reverse transcription polymerase chain reaction (qRT-PCR) assay was developed to quantify CD44v6 and integrin-β1 gene expression in peripheral blood...

  • B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma. Min Fan; Qianfeng Zhuang; Yiming Chen; Tao Ding; Hongwei Yao; Lujun Chen; Xiaozhou He; Xianlin Xu // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 10, p6768 

    Objective: To investigate the mRNA and protein levels of B7-H4, a B7 family molecule, in human urothelial cell carcinoma (UCC), to analyze the relationship between B7-H4 protein expression level and pathological stage of UCC, and to examine the potential of B7-H4 as a prognostic factor in UCC....

  • Role of KIF2A in the progression and metastasis of human glioma. XIN ZHANG; CHAO MA; QINGJIE WANG; JIA LIU; MINGYI TIAN; YUCHANG YUAN; XINGANG LI; XUN QU // Molecular Medicine Reports;2016, Vol. 13 Issue 2, p1781 

    KIF2A is a member of the kinesin‑13 family and is involved in cell mitosis and spindle assembly. The abnormal expression and dysfunction of KIF2A are associated with tumorigenesis and the progression of certain human cancer types; however, little is known about the expression and roles of...

  • Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo. Wang, Wen-Juan; Yao, Yu; Jiang, Li-Li; Hu, Ting-Hua; Ma, Jie-Qun; Liao, Zi-Jun; Yao, Jun-Tao; Li, Dong-Fan; Wang, Shu-Hong; Nan, Ke-Jun // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Expression of lymphoid enhancer factor 1 (LEF1) is frequently altered in different human cancers. This study aimed to assess LEF1 expression in colon cancer tissues and to explore changed phenotypes, gene expressions, and the possible mechanism after knocked down LEF1 expression in colon cancer...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics